<?xml version="1.0" encoding="UTF-8"?>
<p id="p0185">Within pre-clinical discovery, understanding pathogen biology and developing the appropriate animal challenge models are seen as significant limiting factors, especially with emerging infectious disease. The ability to screen, test, and verify potential new antigens is of critical importance. Increased research funding into standardised methodologies for 
 <italic>in vitro</italic> and 
 <italic>in vivo</italic> testing and work into human-livestock host immunology would be critical to increase capacity.
</p>
